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Abstract Oscillatory ﬂuctuations in the cytosolic con-
centration of free calcium ions (Ca
2?) are considered a
ubiquitous mechanism for controlling multiple cellular
processes. Inositol 1,4,5-trisphosphate (IP3) receptors
(IP3R) are intracellular Ca
2? release channels that mediate
Ca
2? release from endoplasmic reticulum (ER) Ca
2?
stores. The three IP3R subtypes described so far exhibit
differential structural, biophysical, and biochemical prop-
erties. Subtype speciﬁc regulation of IP3R by the endoge-
nous modulators IP3,C a
2?, protein kinases and associated
proteins have been thoroughly examined. In this article we
will review the contribution of each IP3R subtype in
shaping cytosolic Ca
2? oscillations.
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Abbreviations
Ca
2? Calcium
CCK-OP Cholecystokinin octapeptide
IP3 Inositol 1,4,5-trisphosphate
IP3RI P 3 receptor
IP3R1, 2 and 3 IP3R subtype 1, 2, and 3
ER Endoplasmic reticulum
PLC Phospholipase C
IICR IP3-induced Ca
2? release
CaM Calmodulin
PKA cAMP-dependent protein kinase
PKC Protein kinase C
CaMKII Ca
2?/CaM-dependent protein kinase II
CTT COOH-terminal tail
CICR Ca
2?-induced Ca
2? release
AKAP PKA-anchoring adaptor protein
LIZ leucine/isoleucine zipper
PS Presenilin
PS1 and PS2 Presenilin-1 and Presenilin-2
FAD Familial Alzheimer0s disease
GIT G-protein-coupled receptor kinase-
interacting protein
NCS-1 Neuronal Ca
2? sensor 1
Introduction
Intracellular calcium (Ca
2?) dynamics play pivotal roles in
numerous physiological processes, including fertilization,
cell proliferation and differentiation, apoptosis, embryonic
development, secretion, muscle contraction, immunity,
brain function, chemical senses, and light transduction [1,
2]. Two main Ca
2? mobilizing systems co-exist in the
cell: Ca
2? inﬂux from the extracellular medium and Ca
2?
release from internal stores. The inositol 1,4,5-trisphos-
phate (IP3) receptor (IP3R) is a tetrameric intracellular IP3-
gated Ca
2? release channel that is predominantly located
on the membrane of the endoplasmic reticulum (ER). It
is present in almost all cell types and plays a crucial role
in converting extracellular stimuli into intracellular signals
[1, 3]. Upon extracellular stimulation by various agonists,
such as hormones, growth factors, neurotransmitters, neu-
rotrophins, odorants, and light, Phospholipase-C (PLC) is
activated and phosphatidylinositol 4,5-bisphosphate is
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to the IP3-induced Ca
2? release (IICR) from the ER. Thirty
years ago, Mikoshiba et al. found a mutant mouse with
deﬁcient Purkinje cells that had very low expression of
P400, a glycoprotein that was later uncovered as one of the
IP3R subtypes (IP3R1) [4, 5]. In 1989, Mikoshiba and
co-workers were the ﬁrst group to reveal that IP3R is a trans-
membrane protein and determine the primary sequence of
IP3R1, at the time the second largest molecule successfully
cloned [6]. So far, three IP3R subtypes (IP3R1, IP3R2,
IP3R3) as well as alternative splicing variants of IP3R1 and
IP3R2 have been identiﬁed and cloned in mammals [1].
The expression patterns of the three subtypes are distinct
but overlapping, and most cells express more than one
subtype [7–9]. The three IP3R subtypes share 65–85%
homology and can be separated into ﬁve functional
domains [1, 10–12]. The NH2-terminal region contains a
ligand coupling/suppressor domain, which suppresses IP3-
binding activity and determines different IP3-binding
afﬁnity for each subtype [13], and an IP3-binding core
domain that is the minimum region required for speciﬁc IP3
binding [14]. The ligand coupling/suppressor domain and
the IP3-binding core are often referred to as the IP3-binding
domain. Besides the IP3-binding domain is the internal
coupling domain, which confers regulation by various
intracellular modulators (Ca
2?, calmodulin (CaM), ATP)
and phosphorylation by several protein kinases (cAMP-
dependent protein kinase (PKA), protein kinase C (PKC),
cGMP-dependent protein kinase, Ca
2?/CaM-dependent
protein kinase II (CamKII), and tyrosine kinase) [3]. The
COOH-terminal region has a six membrane-spanning
channel domain and a short cytoplasmic COOH-terminal
tail (CTT), called the ‘‘gatekeeper domain’’, which is
critical for IP3R channel opening [10]. The Ca
2? release
activity of the IP3R channel is therefore regulated by many
intracellular modulators (IP3,C a
2?, ATP, CaM), protein
kinases, and IP3R-binding proteins [1, 3], leading to vari-
ous spatiotemporal cytosolic Ca
2? patterns and diverse
cellular responses [1, 2]. The relatively low homology in
the three IP3R subtypes may underlie subtype-speciﬁc
properties, that will affect Ca
2? signaling and in particular
the spatiotemporal features of Ca
2? responses.
A prolonged elevation in the cytosolic Ca
2? concen-
tration is considered toxic to the cell and in some cases
may result in cell death. However, the cell can protect itself
by temporally limiting the cytosolic Ca
2? elevation, often
resulting in one of the most delicate patterns of Ca
2? sig-
nals, that being the oscillatory change in the cytosolic Ca
2?
concentration, or Ca
2? oscillations [15–17]. Extensive
studies over the past 30 years have revealed that cytosolic
Ca
2? oscillations are ubiquitous and diverse cellular sig-
nals that control multiple processes in the cell. With
cytosolic Ca
2? oscillations, cells not only avoid deleterious
effects of sustained cytosolic Ca
2? concentrations, but also
send out information encoded in the frequency and/or the
amplitude of the oscillations to modulate cellular activity
[15]. This review focuses on the separate role of the IP3R
subtypes in generating Ca
2? oscillations and on the
molecular mechanisms responsible for the speciﬁc role of
each subtype in regulating this ubiquitous signal.
A General Mechanism Generating Ca
21 Oscillations
Based on Regulation of IP3R
Many studies have indicated that IP3R is involved in
generating cytosolic Ca
2? oscillations [15–17]. For
instance, the FGF-induced Ca
2? oscillations in mice
ﬁbroblasts are inhibited by an IP3R antagonist [18]. Ca
2?
oscillations are thought to arise due to periodic release of
Ca
2? from intracellular Ca
2? stores via IP3R[ 19]. Early
studies using reconstituted IP3R in lipid bilayers have
indicated that Ca
2? can both activate and inhibit IP3R[ 20,
21]. The IP3R is activated at low cytosolic Ca
2? concen-
trations, elevating the cytosolic Ca
2? concentration
through a process often referred to as Ca
2?-induced Ca
2?
release (CICR). High cytosolic Ca
2? concentration can
instead inhibit IP3R, leading to a decrease in intracellular
Ca
2? release. In vivo, the binding of IP3 together with
ﬂuctuating cytosolic Ca
2? concentrations can trigger suc-
cessive cycles of IP3R activation and inhibition, which
result in cytosolic Ca
2? oscillations. Accordingly, Ca
2?
oscillations can be produced by application of IP3 to per-
meabilized hepatocytes [22] and blowﬂy salivary gland
cells [23] and by injecting IP3 analogs into fertilized
ascidians eggs [24]. Moreover, DT40 cells expressing a
mutant IP3R with reduced sensitivity to Ca
2? do not exhibit
Ca
2? oscillations upon application of cross-linked B-cell
receptors [25]. Finally, thimerosal, which sensitizes IP3R
for lower IP3 levels, potentiates IP3-induced Ca
2? oscilla-
tions in sea urchin eggs [26]. These data, together with
mathematical models [27, 28], have conﬁrmed that the
cross-talk between Ca
2? and IP3 in regulating the IP3Ri s
critical for generating Ca
2? oscillations. However, in
Madin-Darbycaninekidneyepithelialcells[29]andChinese
hamster ovary cells [30–32], each peak of the oscillatory
Ca
2? signal is preceded by elevated IP3, as measured by
means of a pleckstrin homology domain of PLC-d1 tagged
with a ﬂuorescent protein indicator. Therefore, it has been
proposed that dynamic IP3 production may produce cyto-
solic Ca
2? oscillations. Nevertheless, other studies using
different cells and methods reported opposite conclusions
[33–35]. For example, expression of an IP3 binding domain
of IP3R1 together with two different ﬂuorescent proteins in
HeLa cells does not reveal ﬂuctuations in the intracellular
IP3 concentration during Ca
2? oscillations [33].
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21 Oscillations
Numerous studies using cells endogenously or exogenously
expressing single or combined IP3R subtypes indicate that
the subtle distinctions in the properties of each subtype
contribute differently to the regulation of cytosolic Ca
2?
oscillations [3].
Miyakawa et al. [36] ﬁrst described IP3R subtype-spe-
ciﬁc Ca
2? oscillations using genetically engineered B cells
that express either single or combined IP3R subtypes. They
found that Ca
2?-signaling patterns depend on the expres-
sion levels of IP3R subtypes, probably because of their
speciﬁc response to endogenous modulators, such as IP3,
Ca
2? and ATP. IP3R2 is the most sensitive to IP3 and is
required for robust, long lasting, and regular Ca
2? oscil-
lations that occur upon activation of B-cell receptors.
IP3R1 mediates less regular Ca
2? oscillations. IP3R3 is the
least sensitive to IP3 as well as Ca
2? and generates only
monophasic Ca
2? transients. Morel et al. [37] examined the
roles of IP3R1 and IP3R2 in Ca
2? oscillations using vas-
cular myocytes and found that acetylcholine induces Ca
2?
oscillations in cells expressing both subtypes, and fails to
do so in cells expressing only IP3R1. The oscillations are
inhibited by intracellular infusion of heparin, anti-IP3R2
antibody or antisense oligonucleotides targeting IP3R2,
suggesting that the IP3R2 subtype is required for acetyl-
choline-induced Ca
2? oscillations in vascular myocytes.
Using HeLa cells, which express comparable amounts of
IP3R1 and IP3R3, Mikoshiba and co-workers showed that
knockdown of IP3R1 terminates Ca
2? oscillations, whereas
knockdown of IP3R3 leads to more robust and long lasting
Ca
2? oscillations [38]. These IP3R3 knockdown effects
were similar in COS-7 cells that predominantly express
IP3R3, suggesting that IP3R3 functions as an anti Ca
2?-
oscillatory unit. Almirza et al. reported similar results using
normal kidney ﬁbroblasts, which expresses IP3R1 and
IP3R3 [39]. When IP3R1 or IP3R3 are knocked-down, the
frequency of prostaglandin F2a-induced Ca
2? oscillations is
signiﬁcantly decreased or increased, respectively. In NIH-
3T3 cells, which predominantly express IP3R2 and IP3R3,
ATP activates Ca
2? oscillations [40]. Ca
2? oscillations
were induced by application of carbachol in AR4-2J cells,
which predominantly expresses IP3R2, and in HEK293A
cells in which both IP3R1 and IP3R3 were knocked-down
[41]. The contribution of IP3R2 to Ca
2? oscillations is
further conﬁrmed by the fact that IP3-dependent Ca
2?
oscillations were abolished in osteoclasts of IP3R2
knockout mice [42]. In rat insulinoma RINm5F cells,
which almost exclusively express IP3R3, application of
carbachol or EGF, two agonists that activate PLC through
different receptors, or application of IP3 to permeabilized
cells, elicit transient Ca
2? release and does not induce Ca
2?
oscillations [43]. Several reports, including mathematical
modeling studies, have indicated that the speciﬁc intra-
cellular localization of the IP3R is crucial for the generation
of Ca
2? oscillations [44–46]. For instance, Kim et al. [45]
found that HL-1 cells derived from mouse cardiac myo-
cytes express both IP3R1 and IP3R2. IP3R1 is expressed
diffusely in the perinucleus and IP3R2 is expressed in the
cytosol with a punctuated distribution. Both application of
ATP to intact cells and direct introduction of IP3 into
permeabilized cells evoke IP3-dependent transient intra-
cellular Ca
2? release accompanied by Ca
2? oscillations.
The magnitude of Ca
2? oscillations is signiﬁcantly larger
in the cytosol than in the nucleus, while the monophasic
Ca
2? transient is more pronounced in the nucleus. These
results suggest that subtype speciﬁcity as well as speciﬁc
localization of the IP3R contribute to distinct local Ca
2?
signaling. Altogether, these data suggest that IP3R1 and
IP3R2, in particular IP3R2, crucially contribute in gener-
ating Ca
2? oscillations, whereas IP3R3 is an anti-oscilla-
tory unit. Nevertheless, in A7r5 cells derived from rat
embryonic thoracic aorta muscle cells, which express
IP3R1 and IP3R3, knockdown of IP3R1 only reduces the
frequency of arginine vasopressin-induced Ca
2? oscilla-
tions without affecting the number of cells exhibiting Ca
2?
oscillations [47]. Moreover, both acetylcholine and chole-
cystokinin octapeptide activate IP3R2- and IP3R3-depen-
dent Ca
2? oscillations in pancreatic acinar cells. However,
unlike IP3R2-dependent oscillations, the amplitude of
IP3R3-dependent oscillations decreases throughout the
stimulation [48]. The IP3R subtype-speciﬁc Ca
2? oscilla-
tions are summarized in Table 1.
The IP3R exists as a homo- or hetero-tetrameric com-
plex to form a functional Ca
2? release channel [49–51].
The inﬂuence of homo- or hetero-tetrameric channels on
intracellular Ca
2? oscillations has been investigated.
Studies on genetically engineered DT40 cells that express a
single IP3R subtype and therefore a homo-tetrameric
receptor demonstrate Ca
2? oscillations [36]. Cells with all
subtypes, which should at least partially express hetero-
tetrameric IP3Rs, also exhibit Ca
2? oscillations [37–43, 45,
47]. Taken together these data suggest that both homo- and
hetero-tetrameric IP3Rs can generate intracellular Ca
2?
oscillations.
In conclusion, it appears that IP3R subtype-speciﬁc
expression crucially shapes cytosolic Ca
2? signaling pat-
terns. IP3R2 is the main pro-oscillatory subtype, whereas
IP3R1 can induce a transient Ca
2? signal or an oscillatory
Ca
2? signal. IP3R3 mainly shows an anti-oscillatory
behavior, but could underlie short-term oscillations
depending on the cell type and stimulus. Further charac-
terization of homo- and hetero-tetrameric IP3R-dependent
Ca
2? oscillations are needed for fully understanding the
intricacies of each IP3R subunit in shaping Ca
2?
oscillations.
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As summarized earlier, cytosolic Ca
2? oscillations are
IP3R subtype-dependent. IP3 and Ca
2? are the two key
modulators of IP3R and the distinct subtype properties
determine the diverse regulatory effects. Each subtype has
different IP3 binding afﬁnity. Sudhof et al. were ﬁrst to
report, using an equilibrium IP3 binding assay, that the
order of IP3-binding afﬁnity was IP3R2[IP3R1[IP3R3
[9, 52]. Applying the same method, Wojcikiewicz et al.
[53] and Nerou et al. [54] later claimed a different order,
IP3R1[IP3R2[IP3R3. Mikoshiba and co-workers per-
formed a detailed molecular analysis of the IP3 binding
afﬁnity of all three subtypes [11, 13]. They found that the
IP3-binding afﬁnities of puriﬁed IP3-binding domains are
close to the intrinsic IP3-binding afﬁnity of all three IP3R
subtypes, and describe the following order IP3R2[
IP3R1[IP3R3. They also showed that IP3-binding core
fragments, which do not contain the ligand coupling/sup-
pressor domain, display an almost identical IP3-binding
afﬁnity for all three subtypes. By a serious and compelling
molecular analysis, they concluded that the functional
diversity in ligand sensitivity among IP3R subtypes arises
from structural differences in the ligand coupling/sup-
pressor domain, which attenuate the IP3-binding afﬁnity of
the IP3-binding core domain through an intramolecular
mechanism. Tu et al. recorded single-channel activities of
the recombinant IP3R1, IP3R2, and IP3R3 reconstituted
into planar lipid bilayers [55]. This report had a similar
conclusion with IP3R2 showing the highest apparent
IP3-afﬁnity, followed by IP3R1, and then by IP3R3.
Differences amongst IP3R subtypes in terms of IP3-bind-
ing afﬁnities do not reﬂect intrinsic differences in the prop-
erties of the channels to regulate Ca
2? oscillations. Instead
differences inthestate ofphosphorylation and/orassociation
with interacting proteins exist. Nevertheless, IP3R1 and
IP3R2 are most sensitive to IP3, a property that could con-
tribute in their function as Ca
2? oscillatory unit. The exact
contribution of subtype speciﬁc IP3-binding afﬁnities on
Ca
2? oscillations remains to be further investigated.
Subtype Speciﬁcity of Ca
21 Inhibition and Induction
As mentioned earlier, repeated activation and inhibition of
IICR by ﬂuctuating cytosolic Ca
2? levels have been pro-
posed as central molecular mechanisms for IP3R-dependent
Ca
2? oscillations [56]. Several stimulatory and inhibitory
Ca
2? binding sites on the IP3R have been identiﬁed and
characterized. For instance, two sites are localized in the
Table 1 The occurrence of Ca
2? oscillations and the expression of the different IP3R subtypes
Cell type IP3R1 IP3R2 IP3R3 Activator Ca
2? oscillations Reference
DT40 ?- -B cell receptor : [36]
DT40 -? -B cell receptor : [36]
DT40 -- ?B cell receptor ; [36]
Vascular myocytes ?? -Acetylcholine : [37]
Vascular myocytes ?- -Acetylcholine ; [37]
HeLa ?? ? ?? (kd) ATP : [38]
HeLa ?? (kd) ?? ? ATP ; [38]
COS-7 ?? ? ? (kd) ATP : [38]
NRK ?- ? (kd) Prostaglandin F 2a : [39]
NRK ? (kd) -? Prostaglandin F 2a ; [39]
NIH-3T3 ?? ? ? ? ATP : [40]
AR4-2 J ?? ? ?IGF-1 : [41]
HEK293A ? (kd) ?? (kd) Carbachol : [41]
Osteoclasts ?? ?RANKL : [42]
Osteoclasts ?- ?RANKL ; [42]
Osteoclasts ?- -RANKL ; [42]
RINm5F ±± ? ? Carbachol, EGF, IP3 ; [43]
HL-1 ?? -ATP : [45]
A7r5 ? (kd) -? Arginine vasopressin ; [47]
Pancreatic acinar cells ?? ?Acetylcholine, CCK-OP : [48]
Pancreatic acinar cells ?- ?Acetylcholine, CCK-OP : [48]
? high expression, - low expression, and kd, knock down or low expression
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transmembrane domain [57], exemplifying the complex
synergy between IP3 and Ca
2? in the regulation of the IICR
[12]. Ca
2? regulation of IP3R activity may result in chan-
ged IP3 binding afﬁnity, alteration of channel open prob-
ability, or indirect inﬂuence on IP3R associated proteins,
such as the CaM. Interestingly, this can occur speciﬁcally
on one IP3R subtype, making Ca
2? regulation of IICR one
of the major mechanisms to produce versatile signals, as
conﬁrmed by mathematical modeling studies [58].
The complex regulation of the IP3R subtypes0 activity by
Ca
2? has been recently reviewed in detail [3] and we will
therefore mainly focus on how Ca
2? itself modulates Ca
2?
oscillations. Everyone in the ﬁeld agrees that all three sub-
types are activated by Ca
2?. Inhibition of the IP3Rb yC a
2?,
however, is more controversial. In single channel studies,
each subtype is inhibited by high Ca
2? concentrations, even
though the threshold and speed of inhibition differs [3].
Moreover, Ca
2? inhibition of IICR sometimes depends on
the addition of an extra factor, for example ATP for IP3R3
[55]. Therefore, all three subtypes can potentially support
Ca
2? oscillations based on the model described previously,
where concerted actions of IP3 and Ca
2? stimulates IP3R.
Accordingly, IP3R1-, IP3R2-, and IP3R3-dependent Ca
2?
oscillations have been observed, although IP3R3-dependent
Ca
2? oscillations are less likely to occur and are also less
frequently observed (see previous sections).
In most cases, cells express more than one IP3R subtype.
Interestingly, when several IP3R subtypes are expressed,
one of them becomes dominant regarding Ca
2? regulation
of IICR [36]. This result also calls for caution when drawing
conclusions on the subtype speciﬁcity of Ca
2? signaling,
since expression of even a small amount of one subtype
could critically affect the Ca
2? signaling pattern [59].
Taken together, Ca
2? activation and inhibition proper-
ties of IP3R1 and IP3R2 make them likely to support Ca
2?
oscillations in physiological conditions [60], whereas spe-
ciﬁc cellular circumstances are required for activation of
IP3R3-dependent Ca
2? oscillations.
Subtype Speciﬁcity of Phosphorylation of IP3R
Phosphorylation of the IP3R is involved in many Ca
2?
signaling pathways [61] and the different subtypes are
interacting with protein kinases and phosphatases differ-
ently [62]. Many of the phosphorylation sites are subtype-
speciﬁc, increasing the diversity in regulatory ﬁne tuning of
Ca
2? oscillations. The functional consequences of these
regulatory modiﬁcations are only partially understood, and
in some cases remain controversial. Therefore we will here
focus on those protein kinases known to modulate Ca
2?
oscillations through phosphorylation of IP3R.
PKA-dependent phosphorylation of IP3R has been
demonstrated extensively. Phosphomimetic mutations of
IP3R1 expressed in DT40 cells showed that PKA-mediated
phosphorylation decreases the threshold for Ca
2? oscilla-
tions, without affecting the amplitude or frequency [63].
PKA phosphorylates two distinct sites in IP3R1 internal
coupling domain (S1588 and S1755) [64]. Although these
sites are not conserved in IP3R2 and IP3R3, PKA-depen-
dent phosphorylation of these subtypes has been demon-
strated [65]. In parotid acinar cells [66] and the pancreatic
AR4-2J cell line [67], PKA directly phosphorylates IP3R2,
dramatically potentiating Ca
2? release. Interestingly, rais-
ing cAMP during sub-threshold agonist stimulation resul-
ted in an oscillatory Ca
2? signal, while raising cAMP
during an Ca
2? oscillation converted the response into a
peak and plateau-like signal [66], probably because of a
shift in the concentration dependency in IICR. CaMKII has
been proposed to be involved in the control of the Ca
2?-
dependent regulation of IICR and in the occurrence of
Ca
2? oscillations [68]. The most extensive information
regarding CaMKII regulation of IP3R is derived from
studies performed on IP3R2 [69, 70], which is the pre-
dominant subtype in cardiac ventricular myocytes. CaM-
KII-dependent phosphorylation signiﬁcantly decreased the
open probability of IP3R2 in lipid bilayers, which suggests
aC a
2?-dependent negative feedback mechanism on IP3R2
activity in the cardiomyocyte nuclear envelope [71]. This
may also result in a Ca
2?-dependent inhibitory loop of
Ca
2? oscillations [72]. Functional effects of PKC-mediated
phosphorylation of the IP3R were ﬁrst studied in isolated
rat liver nuclei [73]. PKC-mediated phosphorylation of
IP3R1 in vitro is in addition regulated by Ca
2? and CaM
[74]. As both Ca
2? and CaM inhibit the PKC-mediated
phosphorylation of IP3R1, it is possible that this pro-
cess may contribute to the negative slope of the
Ca
2?-dependent bell-shaped regulation of IP3Rb yC a
2?,
consequently affecting Ca
2? oscillations. Recent demon-
strations suggest a role for PKC-mediated phosphoryla-
tion of IP3R2 [75] and IP3R3 [43]. These reports show
that when IP3R2 or IP3R3 are phosphorylated by PKC,
IP3-dependent Ca
2? oscillations are decreased in cells
expressing only those subtypes. Thus, PKC may act as a
subtype speciﬁc regulator of IP3R-mediated cytosolic
Ca
2? oscillations. These differences are not unexpected
since IP3R subtypes possess different potential phos-
phorylation sites [43, 76]. How phosphorylation of IP3R
subtypes by distinct protein kinases affect Ca
2? oscilla-
tions are summarized in Table 2.
The subtype speciﬁc regulation of IP3R by phosphory-
lation and its relation to Ca
2? oscillations are not fully
understood. These processes are likely to be dependent on
speciﬁc IP3R subtypes expression levels and protein kina-
ses activation, and need to be further investigated.
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AboutfortyproteinshavebeenreportedtointeractwithIP3R,
most of which modulate IP3R channel activity [1, 3, 77–81].
There is a lack of data regarding IP3R2 and IP3R3 speciﬁc
binding proteinssince mostofthese proteinsare identiﬁedby
co-immunoprecipitation studies with one or two IP3Rs u b -
types or using IP3R1 probes. Few reports show that some of
these associated proteins modulate Ca
2? oscillations differ-
ently. Therefore, we summarize here the proteins that bind to
IP3R and modulate Ca
2? oscillations, whether they bind to a
speciﬁc IP3R subtype or not (Table 2;F i g .1).
Table 2 The IP3R subtype speciﬁcity of protein kinases and IP3R-associated proteins and their modulating effects on Ca
2? oscillations
Effect Stimulatory Inhibitory
Effectors IP3R1 IP3R2 IP3R3 IP3R1 IP3R2 IP3R3
PKC [73, 74]– – – [ 75][ 43]
PKA [63][ 67]– – [ 67]–
CaMKII – – – [68][72]– –
CaBP1 – – – [82]– [ 82]
Na,K-ATPase [83, 84][ 83, 84][ 83, 84]– – –
IRBIT – – – [85]– –
AKAP9 [87]– – – – –
PS1/PS2 [88, 89][ 88, 89][ 88, 89]– – –
ERp44 – – – [90]– –
GRP78 [91]– – – – –
Bcl-2 [78, 92, 94, 96][ 78, 92, 94, 96][ 78, 92, 94, 96][ 97][ 97][ 97]
Bcl-XL [93, 95][ 93, 95][ 93, 95]– – –
Mcl-1 [78][ 78][ 78]– – –
Cytochrome C [98, 99]– – – – –
GIT1/GIT2 – – – [81][ 81][ 81]
NCS-1 [80, 100][ 80, 100][ 80, 100]–– –
Fig. 1 Cartoon illustrating the
three IP3R subtypes (IP3R1,
IP3R2, and IP3R3) and related
protein kinases and interacting
proteins involved in the
regulation of cytosolic Ca
2?
oscillations
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2? binding proteins, was
co-immunoprecipitated with IP3R1 and IP3R3 [82]. The
CaBP1-binding site was mapped in the ligand coupling/
suppressor domain of IP3R1. This interaction functionally
inhibits IP3-dependent Ca
2? oscillations in COS-7 cells
expressing CaBP1, in permeabilized COS-7 cells exposed
to recombinant CaBP1, and in Xenopus oocytes injected
with recombinant CaBP1.
Na,K-ATPase, a plasma membrane ion pump, directly
binds to the IP3 binding-domain of all three IP3R subtypes
through its NH2-terminal tail [83, 84]. In the presence of
ouabain, Na,K-ATPase triggers IP3-dependent Ca
2? oscil-
lations in COS-7 cells and in primary culture of rat renal
proximal tubule cells. Overexpression of a peptide corre-
sponding to the wild type NH2-terminal tail of Na,K-
ATPase decreased the number of cells exhibiting Ca
2?
oscillations, an effect not observed when a mutant type that
does not bind to IP3R was used.
IRBIT was identiﬁed to bind to the IP3 binding core of
IP3R1 [85]. This interaction suppresses the activation of
IP3R by regulating the IP3 sensitivity of IP3R1. Knock-
down of IRBIT in HeLa cells increases ATP-induced
cytosolic Ca
2? oscillations.
AKAP9, one of the neuronal PKA-anchoring adaptor
proteins, binds to the leucine/isoleucine zipper (LIZ) motif
in the internal coupling domain of IP3R1 [86]. Expression
of a 36-residues LIZ fragment, which can disrupt the
IP3R1-AKAP9 association, reduces the frequency of Ca
2?
oscillations induced by application of dopamine in primary
culture of medium spiny neuron [87].
Presenilins (PS), including PS1 and PS2, are proteins
bound to the gamma-secretase protease complex. Mutations
in the genes encoding PS1 and PS2 are the major cause of
familial Alzheimer’s disease (FAD). Wildtype and FAD-
mutants of PS1 and PS2 have been co-immunoprecipitated
with IP3R1 and IP3R3 [88, 89]. These interactions exert
profound stimulatory effects on the IP3R gating activity.
Mutated PSs were demonstrated to increase frequency of
both spontaneous Ca
2? oscillations and Ca
2? oscillations
triggered by cross-linking the B cell receptor with IgM
antibody in both DT40 cells and FAD patient B cells.
ERp44 is an ER lumenal protein of the thioredoxin
family. Depending on the oxidative status in the ER lumen,
it can interact directly with the third IP3R1 lumenal loop
and inhibit its activity [90]. Knockdown of ERp44 in HeLa
cells increases ATP-triggered cytosolic Ca
2? oscillations.
GRP78, another ER lumenal protein, also interacts with
thethirdlumenalloopoftheIP3R1[91].IncontrasttoERp44,
GRP78 enhances IP3R1 channel activity. Knockdown of
GRP78 in HeLa cells decreases ATP-triggered Ca
2? oscil-
lations, which is restored by re-expression of the protein.
Bcl-2, Bcl-XL, and Mcl-1, three anti-apoptotic proteins
that belong to Bcl-2 family, have been reported to bind to
the CTT and/or the internal coupling domain of all three
IP3R subtypes [78, 92–95]. Bcl-2 enhances IP3-mediated
Ca
2? oscillations induced by T cell receptor activation in
WEHI7.2 cells, Jurkat cells, and wild type DT40 cells [78,
92, 94, 96], whereas Ca
2? oscillations induced by serum
withdrawal in NIH-3T3 murine ﬁbroblasts are dampened
[97]. Expression of Bcl-XL in wild type DT40 cells or in
DT40 cells engineered to express each IP3R subtype
increases the number of the cells exhibiting Ca
2? oscilla-
tions as well as the oscillatory frequency [93, 95]. Inter-
action of Mcl-1 with IP3R increases the number of DT40
cells exhibiting anti-B cell receptor antibody induced Ca
2?
oscillations [78]. Bcl-2 and Mcl-1 also increase the number
of cells exhibiting Ca
2? oscillations and the amplitude and/
or the frequency of spontaneous Ca
2? oscillations in DT 40
cells [78].
Cytochrome C, one of the key components of the
apoptotic cascade, was found to selectively and directly
bind to IP3R1 CTT during early apoptosis via a cluster of
glutamic acid residues (binding to IP3R2 and IP3R3 were
not conﬁrmed), resulting in staurosporine-induced sus-
tained Ca
2? oscillations [98, 99].
G-protein-coupled receptor kinase-interacting proteins
(GIT), including GIT1 and GIT2, bind to the CTT of all
three IP3R subtypes, but have stronger binding afﬁnity to
IP3R2 (more than 10- and 20-fold as compared to IP3R1
and IP3R3, respectively), and inhibit IICR [81]. Knock-
down of GIT proteins in HeLa or COS-7 cells increases the
number of cells exhibiting Ca
2? oscillations.
Neuronal Ca
2? sensor 1 (NCS-1), a Ca
2? binding pro-
tein whose expression could be enhanced by application of
Taxol, a natural product for the treatment of solid tumors,
was co-immunoprecipitated with all three subtypes of IP3R
[80, 100]. The NCS-1-IP3R interaction increases the
number of cells exhibiting IP3R-dependent Ca
2? oscilla-
tions in SH-SY5Y human neuroblastoma cells [100] and
the frequency of spontaneous Ca
2? oscillations in rat
ventricular cardiomyocytes [80].
The diversity in distribution of associated proteins and/
or IP3R subtypes is essential for the versatility of IP3R
subtype-dependent Ca
2? oscillations in different cell types.
More information, however, is required for determining the
individual role of each separate subtype in modulating
cytosolic Ca
2? oscillations.
Conclusion and Future Directions
It is evident that the different IP3R subtypes are regulated
by a large number of cellular mechanisms that varies in a
cell type-speciﬁc manner. In this review we have focused
on IP3R subtype-speciﬁc modulation of Ca
2? oscillations.
Ca
2? oscillations are repetitive increases in the cytosolic
Neurochem Res (2011) 36:1175–1185 1181
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2? concentration that are used by the cell to convey
information within or between cells. The oscillatory Ca
2?
signal is known to be initiated at the onset of fertilization
[101–103] and to continue throughout life to control a vast
array of cellular processes as diverse as proliferation, dif-
ferentiation, development, learning and memory, contrac-
tion, secretion, and cell death [1, 15]. Altered intracellular
Ca
2? signaling has been linked to many diseases, such as
Hungtington’s, Alzheimer’s and Parkinson’s diseases,
amyotrophic lateral sclerosis, schizophrenia, spinocerebel-
lar ataxias, heart failure, polycystic kidney disease, and
human immunodeﬁciency virus infection [104–107]. It is
therefore essential to determine the molecular mechanisms
involved in the generation of intracellular Ca
2? oscilla-
tions. Additionally, Ca
2? oscillations are known to encode
information in their frequency and amplitude to activate
various speciﬁc downstream targets [15–17]. Efforts to
understand the nature of these ‘‘cellular radio signals’’
started at the same time as Ca
2? oscillations were dis-
covered and have resulted in a large number of publications
[16–18, 22, 28, 30, 32, 35, 37, 39, 42, 47, 56, 60, 83, 100–
102], most of which is cell type- and agonist-speciﬁc. To
determine the associations between (1) stimulus, (2) Ca
2?
oscillation, and (3) activation of a speciﬁc downstream
cellular process, future studies will have to consider the
molecular partners involved in each step. The recent rapid
development of sophisticated molecular and genetic tools,
such as small interfering RNA [108] and optogenetics
[109], will surely advance our future knowledge about
IP3R subtype-speciﬁc regulation of Ca
2? oscillations.
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